MD, School of Medicine
University of Zaragoza, Zaragoza, Spain
Specialist in Preventive Medicine and Public Health,
University Hospital of Zaragoza and Department of Public Health, Government of Aragón, Zaragoza, Spain
MPH, Institute of Studies in Public Health
University of Valencia, Valencia, Spain
MSc, Epidemiology, School of Medicine
Erasmus University, Rotterdam, Netherlands
Alejandro Arana, MD, MPH, MSc, FISPE, is a Senior Director of Epidemiology at RTI-HS. Dr. Arana has over 29 years of experience in research in pharmacoepidemiology. He has strong experience in regulatory observational studies using different data collection methods in multiple therapeutic areas, including automated health databases. He has authored numerous articles and publications in scientific journals. Particular areas of expertise are neurosciences and epidemiology methods. He also has expertise applying preventive medicine and public health methods to risk management, developing risk minimization strategies, and providing risk minimization assessment evaluation.
Dr. Arana has lectured at the London School of Hygiene & Tropical Medicine, United Kingdom; the Universidad de Barcelona, Spain; the Universidad de Zaragoza, Spain; the Universidade de Aveiro, Portugal; and the Université Saint Antoine, Paris, France. He has participated in several multinational projects addressing epidemiologic and pharmacoepidemiologic issues, including the European Community Concerted Action on the Epidemiology and Prevention of Dementia or Depression Group, the United Nations Project on Acquired Immunodeficiency Syndrome, and the North American Registry of Epileptic Pregnancies.
Dr. Arana is a Fellow of the International Society for Pharmacoepidemiology (ISPE) and chair of the Spanish Chapter of ISPE (Farmaco EpiEnRed). From 2001 to 2011, he was a member of the board of directors of the ISPE and co-chair of the Industry Council of the Society. He is currently a member of the Steering Group of the European Network of Centers of Pharmacovigilance and Pharmacoepidemiology and chairs the Methods Working Group.